Synchrony Financial (NYSE:SYF) on Wednesday lowered the guidance midpoint for full-year net revenue, even after the credit ...

Synchrony Financial logged higher profit and revenue in the third quarter as it returned to purchase volume growth, driven by ...

Synchrony Financial (SYF) reports robust net earnings and strategic partnership growth, despite flat revenue and selective ...

Synchrony Financial (NYSE: SYF) reported better-than-expected earnings for the third quarter on Wednesday. The company posted ...

Synchrony Financial remains a Buy, supported by improved credit quality, strong NIMs & aggressive share buybacks. Learn more ...

Analysts have recently evaluated Synchrony Financial and provided 12-month price targets. The average target is $82.53, ...

"We actually see a little bit more strength in the nonprime [consumer]," CFO Brian Wenzel told American Banker.

Consumer financial services company Synchrony Financial (NYSE:SYF) reported revenue ahead of Wall Street’s expectations in Q3 CY2025, but sales were flat year on year at $3.82 billion. Its GAAP profit ...

Synchrony Financial's strong credit quality, digital growth potential, and compelling valuation outweigh macro risks. Read why SYF stock is a buy.

Synchrony plans to maintain Versatile’s business strategy, management team, and relationships with other lending partners, while accelerating development of new financing technologies.

Shares of Synchrony Financial SYF shed 3.10% to $71.05 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.41% to 6,688.46 and ...

Synchrony Financial has attracted controversy in recent years over its CareCredit subsidiary, which contributed to the firm’s $3.7 billion healthcare lending business in the year ending December 31, ...